Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.33 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2291884 | 0.77 | TSHR (0.35) | TSHRALDH1A1SLC6A2SLC6A4BLM | |
| SCHEMBL19285040 | 0.77 | TSHR (0.35) | TSHRALDH1A1SLC6A2SLC6A4BLM | |
| SCHEMBL19285495 | 0.77 | TSHR (0.35) | TSHRALDH1A1SLC6A2SLC6A4BLM | |
| SCHEMBL28418416 | 0.75 | TSHR (0.33) | TSHRALDH1A1SLC6A2SLC6A4BLM | |
| SCHEMBL9465736 | 0.75 | TSHR (0.33) | TSHRALDH1A1SLC6A2SLC6A4BLM | |
| SCHEMBL9655752 | 0.73 | TSHR (0.34) | TSHRALDH1A1SLC6A2SLC6A4BLM | |
| SCHEMBL9655631 | 0.70 | TSHR (0.32) | TSHRALDH1A1SLC6A2SLC6A4BLM | |
| SCHEMBL9656014 | 0.70 | SLC6A3 (0.38) | TSHRALDH1A1SLC6A2SLC6A4BLM | |
| SCHEMBL22367645 | 0.67 | GRIK1 (0.34) | TSHRALDH1A1CYP2D6CYP2C19GRIK1 | |
| SCHEMBL28243171 | 0.67 | LMNA (0.32) | TSHRALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6852852-B2 | Method of producing regioselectively substituted esters of oligo- and polysaccharides | WOLFF WALSRODE AG (DE) | 2005-02-08 | — | — | US | disclosed |
| EP-1035135-B1 | Regioselectively substituted esters of oligosaccharides and polysaccharides and process for their preparation | WOLFF WALSRODE AG (DE) | 2004-10-13 | — | — | EP | disclosed |
| US-20030162745-A1 | Method of producing regioselectively substituted esters of oligo- and polysaccharides | DOW GLOBAL TECHNOLOGIES INC. | 2003-08-28 | — | — | US | disclosed |
| US-6489468-B1 | REGIOSELECTIVELY SUBSTITUTED, PREDOMINANTLY AT THE C2 POSITION OF THE ANHYDROGLUCOSE UNIT (AGU); STARCH ESTERS | WOLFF WALSRODE AG (DE) | 2002-12-03 | — | — | US | disclosed |
| EP-1035135-A1 | Regioselectively substituted esters of oligosaccharides and polysaccharides and process for their preparation | Wolff Walsrode AG (DE) | 2000-09-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030162745-A1 | Method of producing regioselectively substituted esters of oligo- and polysaccharides | OSTC, SI, OGT | TSHR 3093/4885ALDH1A1 3321/4885SLC6A2 3811/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.